Clinical trials: Type A Aortic Dissection
Type A Aortic Dissection, Ascending Aortic Dissection
Outcomes of Aortic Dissection Repair
Type A aortic dissection (TAAD) is a potentially life-threatening pathology associated with significant risk of mortality and morbidity.
- Conditions
- Type A Aortic Dissection, Ascending Aortic Dissection, Aortic Diseases, Aortic Arch
- Trial name
- STAAD (NCT05927090)
- Testing
- Conservative Root- Sparing Aortic Valve Resuspension with or without Hemiarch Repair, Extensive Ascending Aorta Replacement (AAR) with Aortic Root Replacement (ARR), Extensive Ascending Aorta Replacement (AAR) with Total Arch Replacement (TARP)
- Where
- France
- Volunteers
- 1,200 people
- Sponsor
- Centre Cardiologique du Nord
Acute Aortic Syndrome, Type a Aortic Dissection
Protective Effect of Ulinastatin Against Negative Inflammatory Response and Organ Dysfunction After Acute Type a Aortic Dissection Surgery (PANDA I)
Acute Aortic Syndrome (AAS) is a common feature of acute aortic wall events, including aortic dissection, intramural hematoma, aortic ulceration and aortic trauma, and occurs in up to 35 cases per 100,000 cases per year between…
- Trial name
- PANDA (NCT04711889)
- Testing
- Ulinastatin, Blank control
- Where
- 2 sites in China
- Volunteers
- 203 people
- Sponsor
- Nanjing Medical University
Aortic Dissection Type A
CT Evaluation of Intimal Flap Mobility
Type A aortic dissection is an emergency condition, defined by the appearance of an intimal flap within the ascending aorta. Urgent treatment is required, with surgical replacement of - at minima - the tubular portion of the…
- Trial name
- CT-MOBILITY (NCT03787277)
- Where
- France
- Volunteers
- 50 people
- Sponsor
- University Hospital, Strasbourg, France
Acute Aortic Dissection
PERSEVERE- A Trial to Evaluate AMDS in Acute DeBakey Type I Dissection
Prospective, non-randomized, multicenter clinical investigation to assess the safety and effectiveness of AMDS in the treatment of patients with acute DeBakey type I dissection, with evidence of malperfusion, through open…
- Trial name
- PERSEVERE (NCT05174767)
- Testing
- AMDS
- Where
- 25 sites in United States
- Volunteers
- 115 people
- Sponsor
- Artivion Inc.
Aortic Dissection Type A, Transfusions
Use of PRP in Open Surgery for Type A Aortic Dissection
The goal of this clinical trial is to determine if autologous platelet rich plasma (PRP) can reduce the need for blood transfusions in patients undergoing open surgery for Type A aortic dissection.
- Conditions
- Aortic Dissection Type A, Transfusions, Platelet Rich Plasma (PRP), Organ Protection
- Trial name
- NCT07005661
- Testing
- Autologous Platelet Rich Plasma, Standard Blood Management
- Volunteers
- 250 people
- Sponsor
- Beijing Anzhen Hospital
Ehlers-Danlos Syndrome, Vascular Type
Angiotensin II Receptor Blockade in Vascular Ehlers Danlos Syndrome (ARCADE)
This study aims to verify the hypothesis that patients with Vascular Ehlers Danlos syndrome (vEDS) should benefit of the blockade of angiotensin (Ang) II noxious effects on their vasculature affected by a defect in type III…
- Trial name
- ARCADE (NCT02597361)
- Testing
- Irbesartan
- Where
- 15 sites in France
- Volunteers
- 61 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Type B Aortic Dissection
Real-World Prospective Parallel Controlled Study on Endovascular Therapy for Improving Perfusion and Remodeling of TBAD
There are both common and individual characteristics in patients with type B aortic dissection. Currently, for all subtypes of acute type B dissection, proximal endovascular repair is mostly performed during the subacute phase…
- Trial name
- NCT07022145
- Testing
- Endovascular repair
- Volunteers
- 438 people
- Sponsor
- Shanghai Zhongshan Hospital
Aortic Dissection
Prospective Study of Tailored Management Strategies for Malperfusion Syndrome
Management strategy of malperfusion syndrome in acute type A aortic dissection (ATAAD) patients remains controversial, with different views on when the surgery should be offered.
- Trial name
- NCT05517356
- Testing
- Tailored management strategies
- Where
- China
- Volunteers
- 120 people
- Sponsor
- Xiamen Cardiovascular Hospital, Xiamen University
Type A Aortic Dissection
European Registry of Type A Aortic Dissection
Acute Stanford type A aortic dissection (TAAD) is a life-threatening condition. Surgery is usually performed as a salvage procedure and is associated with significant postoperative early mortality and morbidity.
- Trial name
- ERTAAD (NCT04831073)
- Testing
- Surgery on the ascending aorta with or without repair of the aortic root and/or aortic arch
- Where
- 20 sites in Belgium, Czechia and 6 more
- Volunteers
- 3,902 people
- Sponsor
- Helsinki University Central Hospital
Aneurysm, Dissecting, Acute Kidney Injury
Prediction of Acute Kidney Injury After Operation of Acute Type A Aortic Dissection Based on Multimodal Model
Acute kidney injury is one of the most common postoperative complications of acute type A aortic dissection, which is closely related to early postoperative death.
- Trial name
- NCT05017896
- Testing
- Normal CT Renal Perfusion imaging indexes, Low CT Renal Perfusion imaging indexes
- Volunteers
- 242 people
- Sponsor
- Qilu Hospital of Shandong University
Type A Aortic Dissection
BioGlue as an Adjunct for Structural Repair and Hemostasis in Chinese Acute Type A Aortic Dissections Patients
A multi-center, randomized, controlled clinical trial is designed to investigate the safety and efficacy of BioGlue as an adjunct for structural repair and hemostasis to traditional surgical repair in Chinese subject with Acute…
- Trial name
- CHINA (NCT03369977)
- Testing
- BioGlue Surgical Adhesive, Traditional Surgical Repair
- Where
- 7 sites in China
- Volunteers
- 202 people
- Sponsor
- CryoLife, Inc.
Thoracic Aortic Dissection, Thoracic Aortic Disease
Real-world Study on Fenestrated Stent for Thoracic Aortic Dissection
Study Title: "Multi-center Real-world Study on Straight Tubular Thoracic Aortic Perforated Stent-Graft System for Treating Thoracic Aortic Dissection" Purpose: This study aims to evaluate the effectiveness of the Talos…
- Trial name
- NCT07268755
- Testing
- TALOS
- Where
- China
- Volunteers
- 320 people
- Sponsor
- Qingyou Meng
Type A Aortic Dissection
Surgical Management of the Aortic Root and Long-term Outcomes For Acute Type A Aortic Dissection
The investigators focus on the patients who underwent aortic root surgery for acute type A aortic dissection between 2005.01-2021.11.
- Trial name
- NCT05346497
- Testing
- Bentall, David, ARR
- Volunteers
- 1,600 people
- Sponsor
- Shanghai Zhongshan Hospital
Type B Aortic Dissection
A Study in SurvIvors of Type B Aortic Dissection Undergoing Stenting
Cohort study according to national regulatory guidelines: Non-interventional, observational cohort study. Pair-matched comparison with patients chosen from historical series.
- Trial name
- ASSIST (NCT01407159)
- Where
- 15 sites in Germany, Italy and 2 more
- Volunteers
- 40 people
- Sponsor
- JOTEC GmbH
Marfan Syndrome, Loeys-Dietz Syndrome
Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes
The primary objective of this study is to determine whether specific patterns of circulating micro-ribonucleic acids (miRNAs) are associated with aortic aneurysm and dissection in patients with hereditary aortopathy syndromes.
- Conditions
- Marfan Syndrome, Loeys-Dietz Syndrome, Thoracic Aortic Aneurysm and Dissection Syndromes, Ehlers-Danlos Type IV Syndrome
- Trial name
- NCT02213484
- Where
- 2 sites in United States
- Volunteers
- 20 people, healthy volunteers welcome
- Sponsor
- University of Colorado, Denver
Aortic Dissection Type B
Safety and Efficacy of TEVAR Combined With Long Bare-metal Stents in the Intervention of ATBAD
The primary objective of this study is to evaluate the safety and efficacy of the TEVAR combined with extended bare-metal stenting (distal landing zone ≥2 cm below renal arteries) in patients with acute complicated type B aortic…
- Trial name
- SAFE-COVER (NCT06892730)
- Testing
- Hybrid TEVAR combined with long bare-metal stent intervention
- Where
- China
- Volunteers
- 200 people
- Sponsor
- Yan'an Affiliated Hospital of Kunming Medical University
Aortic Dissection
GORE® Ascending Stent Graft in the Treatment of De Novo Type A Aortic Dissections
To assess the safety and effectiveness of the ASG device in the treatment of de novo Type A aortic dissections.
- Trial name
- ARISE III (NCT06827990)
- Testing
- GORE® Ascending Stent Graft (ASG device)
- Where
- 22 sites in United States
- Volunteers
- 112 people
- Sponsor
- W.L.Gore & Associates
Acute Type A Aortic Dissection
Comparative Study of Antegrade Versus Retrograde Cerebral Perfusion in Acute Type A Aortic Dissection: A Prospective Study
This prospective study investigated the comparison of effectiveness of antegrade cerebral perfusion (ACP) and retrograde cerebral perfusion (RCP) in providing cerebral protection during the surgical treatment of acute Type A…
- Trial name
- NCT06870513
- Testing
- Antegrade Cerebral Perfusion via Axillary Artery, Retrograde Cerebral Perfusion via Superior Vena Cava
- Where
- Egypt
- Volunteers
- 116 people
- Sponsor
- Yusuf Shieba
Vascular Ehlers-Danlos Syndrome
Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos Syndrome
This is a prospective, Phase 3, randomized, double-blind, placebo-controlled efficacy study to evaluate celiprolol in patients genetically confirmed as COL3A1-positive vEDS using a decentralized clinical trial design.
- Trial name
- DiSCOVER (NCT05432466)
- Testing
- ACER-002 (celiprolol) 200 mg BID
- Where
- United States
- Volunteers
- 150 people
- Sponsor
- Acer Therapeutics Inc.
Vascular Ehlers-Danlos Syndrome
Investigate Efficacy, Safety, and Pharmacokinetics of Enzastaurin for the Prevention of Arterial Events in Patients With Vascular Ehlers-Danlos Syndrome.
The purpose of this study is to investigate the efficacy of enzastaurin compared to placebo in preventing arterial events (rupture, dissection, pseudoaneurysm, carotid-cavernous sinus fistula, or aneurysm, fatal or not) leading…
- Trial name
- PREVEnt (NCT05463679)
- Testing
- Enzastaurin
- Where
- United States
- Volunteers
- 260 people
- Sponsor
- Aytu BioPharma, Inc.